Consonance Capital Management LP Intra Cellular Therapies, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$14.35 - $26.64 $23.7 Million - $44.1 Million
-1,654,600 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $3.94 Million - $10.6 Million
-320,400 Reduced 16.22%
1,654,600 $25.4 Million
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $14.2 Million - $75.2 Million
1,955,000 Added 9775.0%
1,975,000 $67.8 Million
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $149,400 - $280,600
20,000 New
20,000 $149,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email